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 Since its initial identification in 1983, the human immunodeficiency virus (HIV) has 




HIV is a member of the 
lentivirus family that targets the host’s immune cells and utilizes enzyme reverse 
transcriptase to encode viral DNA
2
.  After initial infection, HIV enters a period of clinical 
latency that can last up to ten years
2
.  During this subclinical period, the virus will continue 
to replicate and progressively destroy CD4 lymphocytes of the host immune system.  If left 
untreated, HIV infection will eventually progress into clinical AIDS, characterized by a drop 
in CD4 count of 200 cell/microliters or below and development of opportunistic infections
2
.   
 In 2012, the World Health Organization listed global HIV/AIDS as the sixth leading 
cause of death
3
.  As of 2014, there were an estimated 36.9 million people living with HIV, 
2.0 million new HIV infections, and 1.2 million HIV/AIDS related deaths
4
.  At the height of 
the HIV/AIDS epidemic, AIDS related deaths was the number one killer of men ages 25-44 
years old in the United States
1
.  Although, the rates of HIV infection in the United States 
have decreased significantly since the 1980’s and early 1990’s, it remains a high priority 
public health concern.   
 Before the development and access to antiretroviral therapy (ARTs), the case fatality 
rate of HIV was 100%.  Today we are living in an era where HIV, if treated appropriately, 
can be managed as a chronic disease state.  With the advancement in ARTs, testing methods, 
and risk detection, the culture of prevention and treatment for HIV in the United States is 
changing.  
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Defining the Problem 
 Although the rates of HIV have decreased, the Centers for Disease Control and 
Prevention (CDC) estimates that there are currently over 1.2 million people living with HIV 
in the United States and approximately 50,000 new infections each year
5
.  Furthermore, the 
CDC estimates that 12.8% of those living with HIV remain undiagnosed.  In addition to the 
high prevalence of undiagnosed cases, another challenge to combat is the demographic 
disparity between those who continue to be more highly affected.  Two groups in particular 
carry the majority of HIV burden in the United States.  In 2010, the gay, bisexual, and other 
men who have sex with men (MSM) group, accounted for 63% of all new HIV infections in 
the United States
5
.  Close behind, the burden in the African-American population far 
outnumbered any other racial/ethnic group in the United States, accounting for 44% of all 
new HIV cases
5
.  While these groups comprise the vast majority of HIV cases, they 
discordantly represent a small minority in the overall US population.   
 HIV transmission occurs when bodily fluids from an infected person comes into 
contact with mucous membranes or damaged tissue of an uninfected person
6
.  Bodily fluids 
including blood, semen, vaginal fluids, rectal fluids, and breast milk are the main vehicles for 
human-to-human transmission of HIV
6
.  Sexual contact and intravenous drug use are two of 
the most common methods of HIV transmission.  However, transmission is also possible 
during childbirth, breastfeeding, receipt of blood transfusions, accidental needle sticks, or 
contact with open sores or damaged tissue
6
.   
 HIV is one of the most difficult diseases to diagnosis due to its long asymptomatic, 
subclinical latency period.  Within a few days after primary infection, an individual will 
experience an immediate drop in their CD4 lymphocyte count and an inverse increase in the 
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HIV RNA viral load.  A process called seroconversion will occur throughout the first few 
weeks of initial infection.  As the viral RNA continues to replicate, the virus will begin to 
develop its own antibodies, typically detectable within 9 days to 3 weeks after initial 
infection
7
.  During seroconversion, a proportion of individuals will experience acute flu-like 
symptoms such as fever, chills, fatigue, muscle aches, etc
8
.  Unlike other infectious diseases, 
the unremarkable symptoms of early HIV infection do not provide a strong indication or 
warning that individuals should get tested. While these symptoms can last up to several 
weeks, the acute period will generally self resolve before transitioning into the subclinical 
phase
8
.   
During the subclinical phase the individual’s CD4 counts will rebound and the HIV 
RNA viral load will return to a low level.  Depending on the individual, it is possible to 
remain asymptomatic for many years, while the HIV viral load continues to increase, 
destroying the immune system’s ability to fight infection.  While generally asymptomatic, 
infected individuals are at higher risk for non-opportunistic community infections such as 
UTI’s or cellulitis
9
.  The transition into the clinical phase of disease can be recognized 
through symptoms such as chronic rashes, fungal infections, thrush, and Pneumocystic 
jiroveci pneumonia (PCP)
9
.  During the clinical period, individuals are also at a higher risk 
for opportunistic infections
9
.   
With the continued development of successful antiretroviral therapies, those 
diagnosed with HIV can live longer, healthier, and higher quality lives
10
.  Currently, there are 
six main types of ARTs, classified by their mechanism for obstructing HIV replication along 
different points in the cycle
11
.  These classes include: entry inhibitors, fusion inhibitors, 




.  While ARTs do not provide a cure for HIV, they suppress the 
amount of HIV virus and help immune system fend off potentially fatal infections.  In 
addition to maintaining the health of the infected individual, suppression of the viral load can 





Although antiretroviral therapy has come a long way since the initial approval of 
AZT in 1987, the CDC estimates that only 30% of individuals infected with HIV are virally 
suppressed
1,12
.  Furthermore, they estimate that only 37% of those infected have been 
prescribed ART and only 40% of infected individuals are engaged in care
12
.  The sizeable 
portion of individuals unaware of their infection coupled by the strikingly low percentage of 
people who are virally suppressed, calls for a significant public health intervention.  
It is clear that the United States need a more aggressive solution to bring HIV testing 
and diagnosis to the forefront of medicine.  During the height of the AIDS epidemic, people 
were acutely aware of the dangers and risks of HIV infection.  However currently, the overall 
low rates of HIV have allowed us to become more complacent towards the risk of 
transmission and less proactive about early detection and intervention.  These alarming 
statistics highlight the need re-evaluate the methods being used to recommend and implement 
HIV testing. 
Routine Screening and Associated Challenges 
Earlier diagnosis of HIV is the foundation for initiating an efficient cascade of events 
that include connection to counseling, care coordination, and prescription of ART.  In an 
effort to improve earlier HIV diagnosis and capture individuals who would otherwise go 
undetected, the CDC made revisions their HIV screening recommendations
13
.  These revised 
recommendations called for routine (non-targeted) opt-out HIV screening in all healthcare 
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settings and annual testing for high-risk individuals
13
.  Revised screening recommendations 
were outlined in the MMWR, prepared by Branson et al:   
These recommendations for human immunodeficiency virus (HIV) testing are 
intended for all health-care providers in the public and private sectors, including 
those working in hospital emergency departments, urgent care clinics, inpatient 
services, substance abuse treatment clinics, public health clinics, community clinics, 




For patients in all health-care settings
13
 
• HIV screening is recommended for patients in all health-care settings after 
the patient is notified that testing will be performed unless the patient declines 
(opt-out screening). 
• Persons at high risk for HIV infection should be screened for HIV ate least 
annually. 
 
Opt-out, is one of two main methods employed when approaching and consenting a 
patient for rapid HIV testing.  The opt-out method signifies that the rapid HIV test is treated 
as a standard part of routine care
14
.  If patients do not want testing, they must actively decline 
having a rapid HIV test
14
.  In contrast to opt-out testing, the opt-in method requires that the 
health care provider offer the rapid HIV test as a separate consent that falls beyond the 
standard offered care
14
.  Unless the patient actively provides their consent for a rapid HIV 
test, the procedure will not be performed
14
.  The CDC’s decision to specify opt-out methods 
in the 2006 revised recommendations was based on previous HIV screening research among 
pregnant women, showing some evidence of higher test acceptance rates when using opt-out 
versus opt-in
15
.  However, researchers examining routine HIV screening have noted a limited 
number of studies conducted to determine which methods perform best in the clinical HIV 
screening setting
15
.   
 In addition to opt-in versus opt-out consenting methods, there are several approaches 
that can be utilized to determine whether patients should be offered a rapid HIV test.  These 
three main approaches include: diagnostic testing, targeted screening, and nontargeted 
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screening.  Physician directed diagnostic testing is the narrowest approach, predicated on the 
clinician’s judgment from the clinical evaluation of the individual patient.  After evaluating 
the patient and their potential risks, the physician ultimately determines whether or not the 
patient should be offered a rapid HIV test.  Targeted screening focuses efforts on the 
population instead of the individual, and bases the decision on selected characteristics and 
criteria that indicate whether a patient should be offered a test.  In the case of HIV screening, 
patients who exhibit higher risk characteristics specific to increased risk of HIV infection 
would be offered a test over patients who do not exhibit the risk factors.   Nontargeted 
screening is the broadest method, where any consent-giving patient is offered a test 
regardless of their HIV risk, or lack of risk.   
 There are a variety of benefits and challenges to each of these testing methods.  
Results from a 2009 study conducted by Haukoos et al, compared the detection of HIV 
infection using diagnostic testing versus nontargeted opt-out screening
16
.  In comparison to 
the diagnostic testing, the nontargeted opt-out method yielded 30 times more rapid HIV tests 
but identified only a few more patients with new HIV infections
16
.  While nontargeted  
screening can yield an overall higher number of screened patients, the associated cost of both 
resources and labor is higher.  The cost benefit analysis is especially important to consider 
because the number of tests administered to patients will far outweigh the number of HIV 
cases detected. While targeted screening may be more efficient than nontargeted methods for 
HIV detection, there are a number of challenges specific to the targeted approach.  One of the 
largest challenges deals with the stigma associated with categorizing patients by their risk.  
Both patients and health care providers might dislike this method because of concerns for 
invasive questioning or ostracization about an already sensitive subject.  While diagnostic 
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testing may be the most accurate approach and successful at detecting potential HIV infected 
individuals, it does not meet the CDC recommendations. Physicians working in a clinical 
setting have competing priorities and limited time with patients that outweigh their ability to 
routinely implement diagnostic HIV testing
17
.  Screening is a population-based intervention 
that can provide a beneficial solution for improved HIV diagnosis, but one that does not 
come without its own challenges and complexities. 
Acceptance and Barriers to Testing 
 The feasibility of implementing routine HIV screening in healthcare settings is a 
multifaceted process.  In addition to the facility’s size, staff, and resources needed conduct 
widespread rapid HIV screening, patient and provider perception plays an integral role in 
determining what is feasible for the healthcare setting.  Patient perception and acceptance of 
rapid HIV tests have a direct effect on the physician’s willingness to participate in routine 
screening.  There is an intricate relationship that must be examined before implementing 
routine screening, and furthermore, these relationships may not be generalizable across all 
healthcare settings.   
 The Health Belief Model provides a basic foundation for understanding a patient’s 
decision to either accept or decline an offered HIV test.  The model asserts that those who 
recognize the threat of illness or disease will empowered to make decisions to prevent the 
threat
18
.  When applied to HIV screening, individuals who perceive themselves to be at 
higher risk for infection might be more likely to accept an HIV test if offered
19
.  This 
assumption only holds if the individual’s perception of their risk is congruent with their true 
risk.  Unfortunately, this is easier said than done.  In a study conducted in low HIV 
prevalence, the researchers provided evidence that low risk patients inaccurately perceived 
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their risk in comparison to those who reported high-risk behaviors
19
.  Furthermore, a study 
conducted by Nunn et al, looking at the perceived risk in a predominantly urban African-
American community, found that their study population generally underestimated their 
perceived risk of HIV
20
.   Based on the results of multiple studies, it appeared that the 
accuracy of HIV risk perception increased as the individual’s true risk increased
21
.  These 
findings combined with the Health Belief Model lead us to believe that there is a concordant 
relationship between perception of risk and probability of being tested. 
 Aside from individual perception of HIV infection risk, there are a variety of other 
factors and barriers that potentially impact a patient’s probability of accepting a rapid test.  
Researchers looking at factors impacting HIV testing in Australia, Canada, and the UK 
categorized these potential barriers as intrapersonal, interpersonal, and extrapersonal
22
.  
Intimate partner status would be an example of intrapersonal barrier.  It is possible that 
individuals who are currently married might perceive themselves at a lower risk for HIV than 
an individual who is single.  Other intrapersonal barriers include, but are not limited to: 
having been previously tested for HIV, fear of stigma, fear of negative treatment or 
ostracization, fear of inability to cope to infection, and simply preferring not to know HIV 
status
23
.   
 Extrapersonal barriers are often at the community level and to some extent out of the 
control of the individual
22
.  One notable extrapersonal barrier is test acceptance differences 
by race.  On average, African-American patients had the highest rates of HIV test 
acceptance, while white patients generally had the lowest acceptance rates
20,24
.  Additionally, 
previous literature has suggested that test acceptance could differ by gender, with females 
having a higher probability of accepting an offered HIV test in comparison to men
17
.  Other 
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potential extrapersonal barriers could include socio-economic status, access to care, low 
overall knowledge of HIV infection, language barriers and lack of services
22
. 
 Interpersonal barriers aim to explain the critical relationship between the patient and 
the provider.  One of those barriers would include the potential power dynamic between the 
patient and physician.  In some cases, patients are more likely to accept an HIV test if the 
physicians directly recommends that they are tested
22
.  If patients have an overall negative 
experience, perceive a lack of quality care, or do not feel that their privacy is being protected, 
it could negatively impact their decision to be tested
22
.  From the provider perspective, 
several studies have cited physicians’ reluctance to offer patients HIV tests because of 
discomfort in discussing sensitive risk behaviors and disseminating results
25
.  Additional 
provider barriers cited in previous studies have included underestimation of a patient’s HIV 
risk, community level stigma, competing priorities, and skeptical attitudes towards usefulness 
of routine screening
17,22
.   
 Implementing routine HIV screening depends on the dynamic relationship between 
patient and provider. Routine screening is not a feasible solution if providers are not willing 
or able to adhere to the methods for approaching and consenting patients.  If providers feel 
that patients are not at risk for HIV or will decline an offered test, they in turn might be less 
willing to adhere to routine screening protocols.  By understanding factors that determine 
whether or not a patient will accept an HIV test, physicians and healthcare staff can learn 
how to better facilitate and manage the patient perceived barriers.  They will feel more 
comfortable to approach patients and hopefully screening will become a routine part of their 
standard care practice.   
  10 
 Implementation of routine HIV screening requires a multi-faceted approach to 
understanding the dynamic relationship between healthcare facility, provider, and patient.  As 
shown above, there are a wide variety of intrapersonal, interpersonal, and extrapersonal 
factors that can positively or negatively influence a patient’s probability of accepting a test 
and a provider’s willingness to offer a rapid HIV test.  These factors are not isolated 
occurrences and instead must be analyzed together as a working system.   It is important to 
note that significant barriers to testing may differ by population, location, and healthcare 
setting.  A private primary care clinic in a rural setting may encounter barriers much different 
than a hospital emergency department in an urban city.  It is critical to take these differences 
into account and understand the role they play in fulfilling the current routine HIV screening 
recommendations. 
Role of Emergency Departments 
 Emergency departments (ED) are an essential component to the CDC’s initiative to 
increase widespread HIV screening and testing for patients.  Based on the 2011 National 
Ambulatory Medical Survey, there were 136.3 million visits to the US emergency 
departments with an overall incidence of 44.5 visits per 100 persons
26
.  31.8% of the visits to 
US emergency departments in 2011 were billed to Medicaid and 16% of emergency 
department visits were uninsured
26
. Urban EDs provide a particularly unique environment for 
HIV screening due to their wide patient base and ability to assess individuals without access 
to a routine primary care provider.  Furthermore, safety net health care providers  are able to 




Denver Health HIV Research 
  There are several key reasons why the Denver Health Emergency Department is an 
ideal location for studying the feasibility of routine HIV screening. As a public health safety-
net system, Denver Health yields approximately 110,000 emergency department and urgent 
care visits each year, caring for large patient base from the underserved community
27
.   
Serving patients who may be uninsured or do not have a primary are provider allows them to 
capture a more diverse patient population than other healthcare settings.  Moreover, it has 
been estimated that approximately 0.7% of patients who present to the Denver Health ED 
have undiagnosed HIV
16
.  The revised CDC recommendations assert that screening is a cost 
effective program in healthcare settings where the prevalence of undiagnosed HIV is 
≥0.1%
13
.  Implementing routine screening in an environment like Denver Health’s ED is not 
only beneficial for research, but is a critical program that can serve the needs of its 
surrounding community.  The Denver Health team has been at the forefront of testing the 
complexities of implementing rapid HIV testing in urban emergency department settings.   
In 2009, Haukoos et al conducted a quasi-experimental study to compare HIV 
detection using nontargeted opt-out screening versus physician directed diagnostic testing in 
the Denver Health ED patient population
16
.  The 2007-2009 study implemented a five-phase 
trial, alternating between nontargeted opt-out screening and physician directed diagnostic 
testing
16
.  During the three nontargeted opt-out phases, the ED screened 6,933 patients and 
detected 15 new HIV diagnoses
16
.  During the two physician directed diagnostic phases, the 
ED tested 243 patients and detected 4 new HIV diagnoses
16
.   
 In conjunction with the quasi-experimental opt-out phases, Haukoos and his team 
conducted nested cross-sectional surveys of patients who presented to the ED and were 
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offered a rapid HIV test.  Trained research assistants administered the surveys during 
randomly selected eight-hour periods to gather a representative sample of days and hours.  
Over the course of the two-year study, a total of 606 patients consented and completed the 
patient survey.  The surveys gathered a variety of patient level demographic, risk behavior, 
HIV testing perception, and emergency department satisfaction information that can be used 
to evaluate determinants and barriers to HIV test acceptance in the Denver Health ED 
population.   
 In addition to the opt-out screening trial, the Denver Health team recognized the need 
for an empirically based tool to measure patients’ HIV risk.  In 2011, they derived and 
validated the Denver HIV Risk Score, an objective and quantitative measure that could be 
used for implementing targeted screening methods
28
.  The risk score utilized prospectively 
collected data from the Denver Health Metro Clinic and systematically evaluated a number 
of characteristics to derive a clinically meaningful predictive tool for measuring HIV risk
28
. 
The original risk score included 3 demographic (age, race, gender) and 5 risk behavior 
factors, each with an associated numeric positive or negative score
27
.  The sum of the risk 
score ranged from -14 (lowest risk) to +81 (highest risk) and informed clinical cutoffs for 
low, moderate, or high HIV risk
27
.  These clinical cutoffs could inform healthcare providers 
of patients who demonstrate a higher risk of HIV infection and should be offered an HIV 
test.   
Study Aims 
 While there is some qualitative literature that has studied patient patterns, attitudes, 
and barriers to rapid HIV screening, there is a limited number of quantitatively driven studies 
specific to screening in the emergency department.  Furthermore, very few studies have 
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utilized nested cross-sectional survey data within an experimental study to quantitatively 
determine patient factors that impact routine HIV screening.  Studying patient attitudes and 
barriers as a direct result of their nontargeted opt-out HIV screening experience at the 
emergency department has large implications for the implementation of routine screening.  
These findings could determine if test acceptance differs by patient demographics, attitudes 
towards testing, perceptions of risk, and satisfaction with the emergency department care.  
Significant findings could set a precedent for altering or adapting methods used to approach 
patients, in an effort to increase test acceptance rates in the ED.  While the Denver Health ED 
is a unique healthcare setting whose patient base is not necessarily generalizable to all 
healthcare settings, it does set a foundation for understanding patient behaviors and patterns 
towards routine HIV screening.   
 In the context of HIV screening, the Health Belief Model asserts that individuals who 
recognize they are at higher risk of HIV will be more willing to accept screening.  However, 
in high stress, reactive, and treatment-focused settings such as emergency departments, the 
Health Belief Model construct may not hold.  There is high plausibility that patients who 
present to the emergency department and are high risk for HIV will be less likely to accept an 
offered test.  There are potential challenges and opportunities specific to emergency 
departments that can be illuminated through the use of cross-sectional survey data.   
 In this study, we aim to determine the significant demographics, perceptions, and risk 
factors that influence patients’ acceptance or decline of a rapid HIV test in the emergency 
department.  The study population will include the 606 patients who completed the 
satisfaction survey administered during the nontargeted opt-out phases from the 2009 quasi-
experimental study.  Using multivariable logistic regression, the study aims to compare 
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characteristics, behaviors, and perceptions of patients who accepted the rapid HIV test to 
patients who did not accept the rapid HIV test.   
Specific Aim 1 
 Describe the characteristics that affect patients’ decisions to receive a rapid HIV test 
during their visit to the Denver Health Emergency Department.  Hypothesis 1: There will be 
a discordant relationship between risk of HIV infection and probability of HIV test 
acceptance.  Patients who have an empirically defined higher risk of HIV infection, based on 
the Denver HIV Risk Score, are less likely to agree to a rapid HIV test while at the Denver 
Health ED. 
Specific Aim 2 
 Identify demographics and HIV risk characteristics associated with barriers to 
acceptance of a rapid HIV test during their visit to the Denver Health Emergency 
Department.  The four barriers to test acceptance will include: fear of the HIV test result, 
feeling at risk of HIV infection, fear of different treatment if diagnosed positive, and 
preferring HIV testing at a location other than the ED.  Hypothesis 2: Patients with a higher 
risk of HIV, based on the Denver HIV Risk Score, will be more likely to answer “YES” to 
the four barrier questions included in the patient survey.   
Specific Aim 3 
 Evaluate the continuous relationship between patient HIV risk score and probability 
of accepting a rapid HIV test during their visit to the Denver Health Emergency Department.  
Hypothesis 3: There will be a non-linear, quadratic relationship between patient HIV score 
and the probability of accepting a rapid HIV test.  Patients with the lowest and higher risk 





 While HIV infection rates have decreased significantly within the last 20 years, it 
remains a serious public health problem both in the United States and around the globe.  In 
the United States alone there are currently over 1.2 million people living with HIV
5
.  Perhaps 
even more startling is the fact that approximately 12.8% of infected individuals remain 
undiagnosed
5
.  In an effort to increase earlier detection of HIV and improve the downstream 
cascade of care and management, the CDC revised their recommendations for HIV 
screening
13
.  In 2006, the revised recommendations called for routine opt-out HIV screening 
in all healthcare settings and annual testing for high-risk individuals
13
.   
 Emergency departments (ED) are an integral component to the CDC’s initiative to 
increase widespread HIV screening.  Based on the 2011 National Ambulatory Medical 
Survey, there were 136.3 million visits to the US emergency departments with an overall 
incidence of 44.5 visits per 100 persons
26
.  31.8% of the visits to US emergency departments 
in 2011 were billed to Medicaid and 16% of emergency department visits were uninsured
26
. 
Urban EDs provide a particularly unique environment for HIV screening due to their wide 
patient base and ability to assess those without access to a routine primary care provider.  
Furthermore, safety net health care providers are able to capture vulnerable populations who 
are potentially at higher risk of HIV infection. 
 One of the most critical factors in successfully employing routine HIV screening in 
emergency departments is to understand patients’ perceptions of HIV screening and 
furthermore, screening offered in the ED setting.  It is essential to understand patients’ 
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attitudes, patterns of test acceptance, and perceived barriers towards HIV screening.  These 
patient level factors can help determine the impact routine HIV screening has on the ED, best 
methods for approaching patients, what is feasible for long-term implementation.   
 As a public health safety-net system, Denver Health yields approximately 110,000 
emergency department and urgent care visits each year, with a large patient base from the 
underserved community
27
. Moreover, it has been estimated that approximately 0.7% of 
patients who present to the Denver Health ED have undiagnosed HIV
16
.  The revised CDC 
recommendations assert that screening is a cost effective program in healthcare settings 
where the prevalence of undiagnosed HIV is ≥0.1%
13
.  The Denver Health ED is an ideal 
testing environment and has been at the forefront of studying the complexities of 
implementing routine HIV screening in urban emergency department settings.   
 The purpose of this project was to study the determinants and barriers to patient 
acceptance of a rapid HIV test during their visit to the Denver Health emergency department.  
Specifically, we examined the relationship between patient HIV risk and the probability that 
they will accept or decline a rapid HIV test.    
Methods 
 This project utilized a cross-sectional study design to evaluate the association 
between patient HIV risk and probability of HIV test acceptance.   
Data Source 
 Data for this study came from a nested survey conducted in conjunction with a quasi-
experimental “Routine Opt-Out Rapid HIV Screening and Detection of HIV Infection in 
Emergency Department Patients” - study conducted by Haukoos et al at the Denver Health 
Emergency Department during 2007-2009
16
.  Study methods are described in detail 
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elsewhere.  In brief, trained research assistants administered in-person nested cross-sectional 
surveys to ED patients who presented during the nontargeted opt-out phases of the trial.  
Only patients who were offered a rapid HIV test upon presenting to the Denver Health ED 
and who had been in the ED for ≥2 hours were eligible to participate in the survey.  To 
ensure a representative sample of ED days and times, randomly selected 8-hour periods were 
chosen for survey collection.    
 There were 46 questions included on the survey that can be divided into the following 
6 overarching categories: basic demographics, HIV risk behavior and status, satisfaction with 
both the overall ED and HIV screening experience, attitudes towards routine HIV testing, 
and barriers to accepting an HIV test.  It is important to note that certain questions, including 
those pertaining to the HIV screening experience, were only asked of patients who agreed to 
a rapid HIV test.  Likewise, questions regarding barriers to HIV screening were only asked of 
patients who declined a rapid HIV test.  All questions had an option of “Don’t Know” or 
“Refuse to Answer”, to accommodate responses to sensitive questions.   
HIV Risk and Test Acceptance Aim 1 Variables 
 A subset of variables from the survey was chosen as the covariates of interest in the 
primary aim.  Covariates of interest were chosen based on their biologically and theoretically 
plausible association with the study outcome, primary explanatory variable, or both.   
Outcome. The primary outcome was acceptance of the rapid HIV test.  In the original 
dataset, this variable had three responses (Yes, No, Unknown/No Answer).  Observations 




Primary Explanatory Variable. Patient HIV risk, defined by the Denver HIV Risk 
Score, was the primary explanatory variable in this study.  In 2011, the Denver HIV Risk 
Score was derived as a means to empirically define a patient’s HIV risk using 3 demographic 
measures and 5 risk behavior measures.  While the nontargeted opt-out trial was conducted 
prior to the development of the Denver HIV Risk Score, the same demographics and risk 
behavior measures were asked within the patient surveys.  Therefore, it was possible to 
retroactively apply the risk score to each patient in the survey cohort and quantify their HIV 
risk as the primary predictor in this study. 
Patient HIV risk was analyzed in three forms.  To analyze the relationship between 
HIV risk and test acceptance on the multiplicative scale, risk score was used a continuous 
variable ranging from -4 to +51.  As a dichotomous variable, a risk score of <30 was 
categorized as low risk for HIV and scores of ≥30 were categorized as high risk for HIV.  
Finally, risk score was also treated as a categorical variable with three cut points at <30 (low 
risk), 30-39 (moderate risk), and ≥40 (high risk).   
Covariates. Gender, age, race, education level, previous HIV test, time of ED visit, 
satisfaction with ED visit, and perception of HIV testing in the ED were chosen based on 
findings from previous literature and biological/behavioral plausibility.   
Gender options on the survey included male, female, or unknown.  There was only 
one observation with an unknown response for gender.  This observation was deleted from 
the final analysis cohort.  Age was treated as a continuous variable.  In the original survey, 
race was presented as the following categories: American Indian/Alaska Native, Asian, 
Black, Hispanic, White, or Unknown.  To correct for small cell sizes, race was collapsed into 
4 categories that included: White, Hispanic, Non-Hispanic Black, and Other.  Patients who 
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identified as American Indian/Alaska Native, Asian, or Unknown were combined as “Other”.  
Education level was also condensed into 2 categories: ≤high school completion and ≥some 
college.  The one “don’t know” response was combined with the ≤high school completion 
group.  Previous HIV test was coded as never had an HIV test, ever had an HIV test, and had 
an HIV test within the past 12 months.  These responses were mutually exclusive, so survey 
participants could not be counted in both the “ever had an HIV test group” and “the HIV test 
within the past 12 months” group.  Time of survey administration was used as a proxy for 
time of ED visit because the actual time of patient presentation to the ED was not included in 
the dataset.   The ED visit time variable was categorized into three time ranges that covered a 
24-hour period.  Daytime hours were from 08:00-17:59, evening from 18:00-22:59, and night 
hours from 23:00-07:59.      
Satisfaction with the ED visit and perception of HIV testing in the ED were coded 
identically in the survey.  Patients could respond with agree, disagree, don’t know, or refuse 
to answer to the statement “Routine HIV testing should be performed in the Emergency 
Department”.  Similarly, they could respond with agree, disagree, don’t know, or refuse to 
answer to the survey statement “I was satisfied with my Emergency Department visit”.   
HIV Risk and Barriers to HIV Testing Aims 2 Variables 
A variety of demographic and risk behavior measures were chosen as variables of 
interest in the secondary aim.  All covariates were chosen based on their potential association 
with the secondary aim outcome, primary predictor, or both.   
Outcome. There were four separate outcomes based on the four barrier to HIV testing 
survey questions.  Only patients who declined the rapid HIV test were asked these barrier 
questions and therefore, the secondary analysis only included patients who declined the test.  
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The four barrier outcomes were framed as statements that survey participants could respond 
with agree, disagree, don’t know, or refuse to answer.  The barrier question statements 
included - “I was afraid to find out the results of my HIV test”, “I feel at risk of being 
infected with HIV”, “I would rather be tested for HIV somewhere other than the emergency 
department”, and “I am afraid of being treated differently, if the results of the HIV test are 
positive”.  In order to characterize the demographics and risk behaviors of only patients who 
agreed to the barrier questions compared those who disagreed to the barrier questions, all 
other responses were excluded from the analysis.  Excluded observations included patients 
who responded with don’t know, refused to answer, or had a missing answer.   
Primary Explanatory Variable. Similar to aim 1, the primary explanatory variable for 
the secondary aim is patient HIV risk, measured with the Denver HIV Risk Score.  As 
previously mentioned, HIV risk will be analyzed as a continuous, dichotomous (high vs. 
low), and categorical (low, moderate, high) variable.   
Covariates. Gender, age, race, education level, previous HIV tests, relationship status, 
sexual orientation, number of sexual partners within the last 12 months, sex with the opposite 
gender, sex with the same gender, previous STD, and intravenous drug use will be analyzed 
with the secondary aim outcomes.   
Gender, age, race, and education level will be coded in the same manner as 
mentioned above.  In the original survey, relationship status included 5 categories of 
response.  To decrease the number of predictors, responses of divorced and separated were 
combined leaving 4 categorizations for relationship status: married/partnered, 
divorced/separated, widowed, single/never married.  Number of sexual partners within the 
last 12 months was also modified due to the small cell sizes and in an effort to decrease the 
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number of predictors.  Number of sexual partners was categorized into: 0-1, 2-5, ≥6, and no 
response.  I had considered removing observations with no response, but chose to include 
them because of the sizeable percentage of patients with no response.   Sexual orientation 
was coded as a categorical variable with the following survey response options: 
heterosexual/straight, bisexual, homosexual, and other.  Only one participant responded as 
“Other”, but I did not feel confident to combine the response with the heterosexual, bisexual, 
or homosexual categories.   
Previous HIV test, sex with the same gender, sex with the opposite gender, previous 
STD, and intravenous drug use were coded identically.  In the original survey, participants 
could choose ever, never, within the past 12 months, don’t know, or prefer no answer.  
“Within the past 12 months” was combined with “ever”, to limit the number of predictors.  
Statistical Analysis 
 Univariate. For both aim 1 and aim 2, univariate logistic regression was performed in 
SAS 9.4 for all predictor variables to measure if they were independently associated with HIV 
test acceptance or the HIV barrier outcomes.  For categorical variables, chi-square tests were 
utilized to determine if there were significant differences between the categories of exposure 
and the outcome. Chi-square results were considered significant if they produced an alpha 
level <0.05.  Odds ratios were reported for all predictors.  In the survey, there were four 
separate questions that evaluated patient satisfaction with their experience in the emergency 
department.  Due to potential correlation, the four satisfaction questions will be evaluated 
univariately and the question with the highest association with the outcome will be 
considered for the multivariable model.   
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 Multivariable Model. Logistic regression modeling in SAS 9.4 was utilized to fit the 
multivariable models for both the primary and secondary aims.  Early in the modeling 
process, stepwise selection was conducted allowing SAS 9.4 to fit the most statistically 
significant model.  Selective modeling was used to limit the number of predictors in the 
model to covariates that statistically contributed to the model and were biologically plausible.  
To check for residual confounding and observe the effect on the estimate, predictors were 
added one at a time to achieve the final, most parsimonious model.  For both aim 1 and aim 
2, a PROC CORR was utilized to test if covariates considered for the model were highly 
correlated.  Based on the aim 1 directed acyclic graph (Figure 1), Baron-Kenny mediation 
analysis was performed to determine whether the predictor is true mediator in the model.  
Interactions terms were added to test if effect modification was present in the model. 
 B-splines. A series of B-splines were fit in R, to test the non-linear relationship of 
patient HIV risk with the probability of accepting an HIV test.  B-splines were chosen as the 
appropriate method because they did not impose a strict shape on the data.  Both unadjusted 
and adjusted models were fit with different varying degrees of freedom.  The unadjusted 
model only included HIV risk score as the primary predictor.  The adjusted model included 
the primary predictor as well as the covariates included in the final aim 1 regression model.  
AICs and p-values were used to determine which B-spline plot most appropriately fit the 
data.   
  







Figure 1: Directed acyclic graph of patient HIV risk and acceptance of a rapid HIV test. 
Results 
 Of the 696 eligible patients invited to participate in the survey, 606 agreed and 
completed the survey administered by the research assistant.  Of the 90 patients who did not 
complete the survey, 7 agreed to participate but did not complete all survey questions, 58 
declined the invitation to participate, and 25 declined after discussing the study with the 
research assistant.   
 Particular to aim 1, there were 569 patients eligible for the analysis cohort.  Of the 
696 original patients in the survey cohort, 17 patients from the physician directed diagnostic 
phase were excluded.  An additional 109 patients were excluded because their test acceptance 
status was unknown or missing, as well as 1 patient whose gender was also unknown.  The 
final analysis cohort included 199 patients who accepted the HIV test and 370 patients who 




























Figure 2: Diagram of selection process for observations included in the Aim 1 analysis 
survey cohort. 
 
HIV Risk and Test Acceptance Aim 1 Results 
Based on the results from the univariate analysis, race, previous HIV test, and attitude 
of HIV testing in the Emergency Department were independently associated with the 
outcome (Table 1).  On the multiplicative scale patient HIV risk, the odds of accepting an 
HIV test increased by 2% for every point increase on the Denver Health Risk Score.  
Although this estimate showed a positive trend between HIV risk and test acceptance, it did 
not reach statistical significance (95% CI: 1.00, 1.04).  This finding was similar when risk 
was treated as a binary and a categorical variable.  The odds of accepting an HIV test among 
patients with high risk (≥30) was 1.60 (95% CI: 0.95, 2.68) times as high in comparison to 
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patients with low HIV risk (<30).  When risk was treated as a categorical variable, the odds 
of accepting an HIV test increased for patients with moderate and high risk categories in 
comparison to patients with low risk.  Although there was a consistent positive trend between 
HIV risk and test acceptance, the estimates of risk were not significant due to confidence 
intervals that included 1.   
 From the univariate analysis, the probability of test acceptance differed by race.  The 
odds of accepting an HIV test among Non-Hispanic Black patients was 1.67 (95% CI: 1.02, 
2.75) times higher in comparison to white patients.  Additionally, there was a significant 
difference in the odds of test acceptance between patients who identified as an “Other” race 
(OR=2.14, 95% CI: 1.10, 4.17) in comparison to white patients.  Patients included in the 
“Other” race category included American Indian/Alaskan Native, Asian, and unknown.   
 The odds of accepting an HIV test among patients who had reported receiving an HIV 
test within the past 12 months was about 40% lower (95% CI: 0.39, 0.92) in comparison to 
patients who reported ever receiving a previous HIV test.  There was no significant 
difference in test acceptance between patients who had reported never receiving a previous 
HIV test and patients who reported ever receiving a test (OR=1.02).  The odds of HIV test 
acceptance among patients who did not believe routine HIV testing should be performed in 
the ED was about 77% less likely (95%: 0.11, 0.48) in comparison to patients who agreed 
that routine HIV testing should be performed in the ED.  Age, gender, education level, visit 
time to the ED, and satisfaction with the emergency department were not significantly 
associated with the outcome.  There was a potentially notable trend with age, showing that as 
patient age increased, the odds of accepting a rapid HIV test decreased (OR=0.99, 95% CI: 
0.97, 1.00).   
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Table 1: Aim 1 cross-tabulations and univariate analysis of the primary predictor and 
covariates modeling acceptance of a rapid HIV test at the Denver Health ED. 
Variable Name 2009 Non-Targeted HIV Testing 
   Agreed (n=199)         Did not Agree (n=370)                  OR  (CI) 
Risk Score      Mean = 21.63              SD = 8.33 1.02 (1.00, 1.04) 
Risk Score (Binary) 
         ≥30  








1.60 (0.95, 2.68) 
Ref 
Risk Score (Categorical) 
     Low Risk (0-29) 
     Moderate (30-39) 











1.56 (0.83, 2.93) 
1.67 (0.73, 3.80) 
ED Visit Hours  
    Daytime (8:00 – 17:59) 
    Evening (18:00-22:59) 











1.54 (0.99, 2.40) 
0.70 (0.46, 1.05) 
Age (Continuous)       Mean = 42                  SD = 13.6 0.99 (0.97, 1.00) 
Gender 
     Male 









0.91 (0.64, 1.30) 
Race 
     White 
     Hispanic 
     Non-Hispanic Black 













1.15 (0.77, 1.72) 
1.67 (1.02, 2.75) 
2.14 (1.10, 4.17) 
Education 
     ≤High School 
     ≥ Some College 









0.80 (0.57, 1.14) 
Previous HIV Test 
     Within past 12 mo.      
     Ever 










0.60 (0.39, 0.92) 
Ref 
1.02 (0.67, 1.54) 
Routine Testing (Y/N)* 
     Agree 
     Disagree 











0.23 (0.11, 0.48) 
0.57 (0.26, 1.25) 
Satisfied with ED Visit* 
     Yes 
     No 
 







0.80 (0.45, 1.43) 
Felt med. Needs were met* 
     Yes 
     No 











0.68 (0.32, 1.44) 
1.23 (0.49, 3.05) 
Not satisfied w/ quality* 
     Agree 
     Disagree 










0.88 (0.51, 1.54) 
Ref 
1.18 (0.45, 3.10) 
Waited too long in ED* 
     Yes 









1.19 (0.82, 1.73) 




After fitting the full multivariable logistic regression model, the effect of race was 
attenuated and the differences between Non-Hispanic Black patients and other patients in 
comparison to the reference group (white) were no longer significant.  Previous HIV test and 
perception of routine HIV testing in the emergency department remained significant in the 
multivariable model.  Age, treated as a continuous variable, became weakly significant when 
included in the full model.  For every increased year of patient age, the probability of 
accepting a rapid HIV test decreases by 1.7% (95% CI: 0.97, 0.997).   
 In addition to fitting the full multivariable model with the primary predictor and all 
covariates, I fit a stepwise selection model, allowing only variables that met the 0.05 alpha 
level cut off to be included.  In the stepwise model, patient race, age, previous HIV test, visit 
time to the ED, and perception of routine HIV screening in the ED remained significant in 
the model.  Purposeful, selective modeling was used to fit the most parsimonious model.  
Baron-Kenny mediation analysis was performed for the previous HIV test variable and the 
perception of routine HIV screening in the emergency department variable.  For both 
variables, a chi-square test of association was performed between the exposure (risk score as 
a dichotomous variable) and the two potential mediators.  Neither previous HIV test (p=0.09) 
nor the perception of routine HIV screening variable (p=0.89) were associated with patient 
HIV risk score.  Although previous HIV test and perception of routine HIV screening in the 
ED did not meet the assumptions of the Baron-Kinney test for mediation, they were 
significantly associated with the outcome independently and contributed to the multivariable 
model.   
 From the modeling of the directed acyclic graph, visit time to the emergency 
department was suspected to modify the relationship between HIV risk and probability of 
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HIV test acceptance.  To evaluate this possible effect modification, an interaction term 
between patient HIV risk score and visit time to the ED was included in the model.  The 
interaction did not significantly contribute to the model (p=0.80).  Visit time to the 
emergency department was ultimately excluded because it did statistically contribute to the 
model or change the estimate of the primary explanatory variable.   
 The final most parsimonious model included patient HIV risk, race, age, previous 
HIV test, and routine HIV screening in the ED perception.  Individual multivariable models 
were fit to evaluate the primary explanatory variable as continuous, dichotomous, and 
categorical (Table 2, 3, 4).   
Table 2: Aim 1 parsimonious model with HIV risk score treated as a continuous 
variable. 
Predictor Odds Ratio Estimate 95% CI 
HIV Risk  1.02 0.99, 1.04 
Race (Ref = White) 
     Hispanic 
     Non-Hispanic Black 









Age 0.98 0.97, 1.00 
Previous HIV Test (Ref = Ever) 
     Within past 12 months 







HIV Screening in ED (Ref = Agree) 
     Disagree 








Table 3: Aim 1 parsimonious model with HIV risk score treated as a dichotomous 
variable.  
Predictor Odds Ratio Estimate 95% CI 
HIV Risk (Ref = <30) 





Race (Ref = White) 
     Hispanic 
     Non-Hispanic Black 









Age 0.98 0.97, 1.00 
Previous HIV Test (Ref = Ever) 
     Within past 12 months 







HIV Screening in ED (Ref = Agree) 
     Disagree 








Table 4: Aim 1 parsimonious model with HIV risk score treated as a categorical 
variable. 
Predictor Odds Ratio Estimate 95% CI 
HIV Risk (Ref = <30) 
     30-39 







Race (Ref = White) 
     Hispanic 
     Non-Hispanic Black 









Age 0.98 0.97, 1.00 
Previous HIV Test (Ref = Ever) 
     Within past 12 months 







HIV Screening in ED (Ref = Agree) 
     Disagree 








While HIV risk remained nonsignificant in the final multivariable model, the positive 
trend consistent across the continuous, dichotomous, and categorical variable types.   Though 
nonsignificant, the odds of HIV test acceptance increased as patient risk score increased.  
After controlling for the other covariates in the model, the effect of the dichotomized risk 
score was slightly attenuated in comparison to the univariate analysis.  The odds of accepting 
a rapid HIV test among patients in the high risk category was 1.43 (95% CI: 0.82, 2.49) times 
higher than patients in the low risk category.  When risk was treated as a categorical variable, 
the effect size of the moderate risk group (OR=1.20, 95% CI: 0.59, 2.43) compared to the 
reference group was slightly attenuated, whereas the effect size of the high risk group 
increased (OR=1.88, 95% CI: 0.79 4.48).  Similar to the full model, age remained weakly 
associated with the outcome in the final model.  For every year that patient age increased, the 
probability of accepting a rapid HIV test decreased by 1.5% (95% CI: 0.97, 1.00).  
Significant differences in the odds of acceptance by race, previous HIV test, and perception 
of routine HIV screening in the ED were similar to the findings in the univariate analysis and 
the full model.  Patients who identified as Non-Hispanic Black or identified as a race 
  30 
combined into the “other” category had a higher odds of accepting a rapid HIV test in 
comparison to white patients.  Patients who reported receiving an HIV test within the past 12 
months were approximately half as likely to accept an offered test in comparison to the 
patients who reported ever having a previous HIV test (OR=0.51, 95% CI: 0.33, 0.80).  
Finally, patients who did not believe that HIV screening should routine in the emergency 
department were about 75% less likely to accept a test (OR=0.24, 95% CI: 0.11, 0.50).   
Collinearity was a potential concern of using HIV risk score as the primary predictor 
and including covariates in the model that were also components of the risk score.  As 
previously mentioned, the risk score is a sum of the numeric values assigned to each of the 
individual demographic and risk behavior included in the Denver Health Risk Score 
questionnaire
28
.  Gender, age, race, and previous HIV test were components of the risk score 
as well as covariates included in the regression model.  A series of polyserial correlations 
were used examine the potential correlation between HIV risk with age, gender, race, and 
previous HIV test.  I also conducted polychoric and tetrachoric correlations between the 
covariates to determine if any of the variables considered for the model were highly 
correlated with each other.  Based on the low correlation coefficients between the primary 
predictor and its individual components and as well as the low correlation between the 
individual covariates, I felt confident including the variables as independent predictors in the 
model.   
 To test the validity of the risk score estimate, I fit an additional model that dissected 
the risk score into its individual components. The risk score variable was removed from the 
model and replaced by gender, age, race, age, sex with a male, previous HIV test, vaginal 
intercourse, and injection drug use.  The goal of this alternative model was to determine if 
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one variable in particular was skewing the effect size of the association with the outcome.  If 
there was one variable in particular that was highly associated with the outcome, it would 
suggest that the odds ratio estimate of HIV risk was being largely influenced by that single 
variable.    
Table 5: Alternative regression model using the individual components of the HIV risk 
score variable as predictors. 
Predictor Odds Ratio Estimate 95% CI 
Sex with a male (Ref = Never) 





Vaginal intercourse (Ref = Never) 





Intravenous Drug Use (Ref = Never) 





Race (Ref = White) 
     Hispanic 
     Non-Hispanic Black 









Age 0.98 0.97, 1.00 
Previous HIV Test (Ref = Ever) 
     Within past 12 months 







HIV Screening in ED (Ref = Agree) 
     Disagree 








As independent predictors, none of the variables that comprised the HIV risk score 
were significantly associated with the outcome with the exception of race and age (weakly 
associated) (Table 5).  The estimates in the alternative regression model were consistent with 
the effect sizes of the regression model that included the HIV risk score variable.  Therefore, 
I was comfortable using the HIV risk variable as the primary predictor in the model and 






HIV Risk and Barriers to Testing Aim 2 Results 
 In total, there were 4 separate sets of univariate analysis and 4 multivariable 
regression models fit for the secondary aim.  Each barrier question had to be evaluated 
individually as its own outcome.  The study population of the secondary aim was limited to 
369 observations because the barrier questions were only asked of patients who declined the 
rapid HIV test.  The first outcome stated, “I was afraid to find out my HIV test result”.  55 
patients agreed with the statement, 272 disagreed, 18 didn’t know, 2 refused to answer and 
24 had missing/no answer responses.  The second barrier question stated, “I did not feel that I 
was at risk for being infected with HIV”.  288 patients agreed with the statement, 46 
disagreed, 2 didn’t know, and 25 had missing/no answer responses.  The third barrier 
question stated, “I would rather have been tested for HIV somewhere other than the 
Emergency Department”.  54 patients agreed with the statement, 260 disagreed, 31 didn’t 
know, 1 patient refused to answer, and 25 had missing/no answer responses.  The final 
barrier question stated, “I was afraid that if my HIV test result is positive, people would treat 
me differently”.  155 agreed with the statement, 172 disagreed, 17 didn’t know, 2 patients 
refused to answer, and 25 had missing/no answer responses.  Based on the similar numbers 
of missing/no answer responses for each barrier question, it is assumed that the same survey 
respondents did not provide responses.   
Afraid of the HIV Test Result. The first barrier question assessed the differences 
between patients who reported being afraid of their HIV test result compared to patients who 
were not afraid of their HIV test result.  Based on the results of the univariate analysis, HIV 
risk, relationship status, sexual orientation, number of sexual partners with the past 12 
months, sex with the same gender, and injection of street drugs were independently 
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associated with fear of HIV test results (Table 6).  On the multiplicative scale, HIV risk score 
was positively associated with fear of the HIV test results.  When treated as a continuous 
variable, the odds of being afraid of the HIV test results increased 7% (95% CI: 1.03, 1.11), 
for every point that the patients’ HIV risk increased.  On the additive scale, the odds of being 
afraid of the test results among patients in the high risk category was 4.55 (95% CI: 2.12, 
9.77) higher in comparison to patients in the low risk category.  When treated as a categorical 
variable, the moderate risk group (OR=3.32, 95% CI: 1.26, 8.82) and high risk group 
(OR=7.2, 95% CI: 2.30, 22.49) had significantly higher odds of reporting being afraid of 
their test results when compared to the low risk group.   
Interestingly, when looking at differences in response by relationship status, 
participants who identified as widowed had increased odds of being afraid of their test results 
(OR=3.41, 95% CI: 1.72, 9.92) in comparison to participants who identified as 
partnered/married.  The odds of being afraid of the HIV test results among participants who 
identified as homosexual was almost 6 times (95% CI: 2.31, 14.98) higher than patients who 
identified as heterosexual.  There was a significant association between number of sexual 
partners and being afraid of the HIV test results.  In comparison to patients who reported 0-1 
sexual partners within the past 12 months, the odds of feeling afraid were 3.9 (95% CI: 1.72, 
8.80) times higher for those reported 2-5 sexual partners and approximately 6 (95% CI: 
2.090, 17.81) times higher for those who reported 6 or greater sexual partners.  There was 
also a significant difference between participants who had no response to the number of 
sexual partners and being afraid of the HIV test results.  The odds of being afraid among 
those who had no response to number of sexual partners was 2.62 (95% CI: 1.27, 5.38) times 
higher in comparison to those who reported 0-1 sexual partners.  Finally, among those who 
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reported never having sex with the same gender and never injecting street drugs, the odds of 
being afraid were significantly lower than patients who reported ever having sex with the 
same gender (OR = 0.28, 95% CI: 0.14, 0.59) and ever injecting street drugs (OR = 0.44, 
95% CI: 0.21, 0.94).  Gender, race, age, education level, previous HIV test, sex with the 
opposite gender, and previous STDs were not independently associated with being afraid 
with the results of the HIV test.       
Table 6: Aim 2 descriptive statistics and univariate analysis of the primary predictor 
and covariates modeling the probability of being afraid of the HIV test results. 
Variable Name Afraid of HIV Test Results 
     Yes (n=55)                No (n=272)                    OR (95% CI) 
Risk Score Mean = 21.23 SD = 8.2 1.07 (1.03, 1.11) 
Risk Score (Binary) 
     High (≥30) 








4.55 (2.12, 9.77) 
Ref 
Risk Score (Categorical) 
     High (≥40) 
     Moderate (30-39) 










7.20 (2.30, 22.49) 
3.32 (1.25, 8.82) 
Ref 
Gender 
     Male 









0.67 (0.37, 1.22) 
Race 
     White 
     Non-Hispanic Black 
     Hispanic 













1.02 (0.40, 2.51) 
1.22 (0.64, 2.34) 
1.06 (0.29, 3.95) 
Age Mean = 42.99 SD = 13.55 1.00 (0.98, 1.02) 
Education 
     ≤High School 









0.59 (0.33, 1.07) 
Previous HIV Test 
     Ever 









1.33 (0.71, 2.48) 
Relationship Status 
     Married/Partnered 
     Divorced/Separated 
     Widowed 













1.79 (0.78, 4.15) 
3.41 (1.72, 9.92) 
1.48 (0.71, 3.09) 
Sexual Orientation 
     Heterosexual 
     Bisexual 
     Homosexual 













1.47 (0.30, 7.16) 




Table 6 continued. 
Variable Name Afraid of HIV Test Results 
    Yes (n=55)                No (n=272)                     OR (95% CI) 
# of Sexual Partners 
     0-1 
     2-5 
     ≥6 













3.90 (1.72, 8.80) 
6.10 (2.09, 17.81) 
2.62 (1.27, 5.38) 
Sex with Opp. Gender 
     Ever 









0.82 (0.18, 3.76) 
Sex with Same Gender 
     Ever 









0.28 (0.14, 0.59) 
Previous STD 
     Ever 









0.65 (0.34, 1.24) 
Injected Street Drugs 
     Ever 









0.44 (0.21, 0.94) 
 
After the fitting the full regression model, the effect of HIV risk was slightly 
attenuated.  While barely significant on the multiplicative scale, the effect of HIV risk for 
patients in the moderate risk category and HIV risk treated as a dichotomous variable were 
no longer statistically significant.  Out of all the covariates independently associated with the 
outcome in the univariate regression analysis, only sexual partners remained significant in 
the full regression model.  Sexual orientation was excluded from the full regression model 
because it had a high positive correlation to the sex with the same gender variable (0.78).  I 
believe that sex with the same gender is a more accurate representation of HIV risk behavior 
than sexual orientation, and therefore felt confident in removing sexual orientation from the 
model and maintaining sex with the same gender.   
 I decided to fit a stepwise model to understand what would be retained in the model 
purely by statistical significance.  Only HIV risk, education level, and number of sexual 
partners made the 0.05 alpha level cutoff to be included in the model.  It was an interesting 
finding because it did not reflect the results I had seen in the univariate analysis.   
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 In order to achieve the most parsimonious model, I utilized purposeful modeling and 
added variables to the model one by one to observe changes in the effect of the main 
predictor.  Similar to aim 1, I was interested in testing the effect of previous HIV test as a 
potential mediator in the model.  However, the previous HIV test variable did not meet the 
assumption of the Baron-Kenny model because it was not associated with the exposure or 
outcome.  I was also interested to test if the effect of HIV risk varied by education level.  I 
added an interaction term to the model to measure if there was potential effect modification 
occurring.  The interaction did not significantly add to the model (p=0.18) and was then 
excluded from the final parsimonious model.  The final model included HIV risk, previous 
HIV test, number of sexual partners, sex with the same gender, and education level (Table 7, 
8).   
Table 7: Aim 2 parsimonious model with HIV risk treated as a continuous variable 
modeling fear of HIV test result. 
Predictor Odds Ratio Estimate 95% CI 
HIV Risk  1.05 1.01, 1.10 
Previous HIV Test (Ref = Ever) 





# of Sexual Partners (Ref = 0-1) 
    2-5 
     6+ 









Sex with the same gender (Ref = Ever) 





Education level (Ref = ≤High School) 






Table 8: Aim 2 parsimonious model with HIV risk treated as a categorical variable 
modeling fear of HIV test result. 
Predictor Odds Ratio Estimate 95% CI 
HIV Risk (Ref = <30) 
     30-39 







Previous HIV Test (Ref = Ever) 









Table 8 continued. 
Predictor Odds Ratio Estimate 95% CI 
# of Sexual Partners (Ref = 0-1) 
    2-5 
     6+ 









Sex with the same gender (Ref = 
Ever) 





Education level (Ref = ≤High 
School) 






 The effect sizes differed slightly between the models when risk was treated as a 
continuous variable versus categorical variable.  In the final model, the positive relationship 
between HIV risk and probability of being afraid of the HIV test results remained significant.  
In the model when HIV was treated as a categorical model, only the high risk group 
remained statistically significant.  Also, education level only remained statistically significant 
in the model where risk was treated as a categorical variable.  The odds of being afraid of the 
HIV test results among those who had some college or more was 39% lower (95% CI: 0.27, 
0.98) in comparison to those with a high school education or less.  Number of sexual partners 
remained significant in both models regardless of risk score.  Although not significantly 
associated with the outcome, previous HIV test and sex with the same gender were included 
in the model for biological plausibility.   
Feeling at Risk of Being Infected. The second barrier question assessed whether 
participants felt they were at risk for being infected with HIV.  Approximately 16% of survey 
participants responded that they felt at risk for being infected with HIV.  From the univariate 
analysis results, only gender and number of sexual partners were significantly associated 
with feeling at risk for HIV infection (Table 9).  For gender, females were weakly associated 
with feeling less at risk for being infected with HIV (OR=0.54, 95% CI: 0.29, 0.99) in 
comparison to males.  The odds of feeling at risk for being infected with HIV among patients 
  38 
who reported having 2-5 sexual partners in the past 12 months was 2.76 times (95% CI: 1.27, 
5.98) higher in comparison to partners who reported 0-1 partners.  While there was a positive 
trend in HIV risk and feeling at risk for HIV infection, the estimates were nonsignificant 
when evaluated univariately.   
Table 9: Aim 2 descriptive statistics and univariate analysis of the primary predictor 
and covariates modeling the probability of feeling at risk for HIV infection. 
Variable Name 2009 Opt-Out –Feel at risk for being infected with HIV 
  Agree (n=56)         Disagree (n=288)               OR (95% CI) 
Risk Score Mean = 21.17 SD = 8.2 1.02 (0.99, 1.06) 
Risk Score (Dichotomous) 
     High (≥30) 








1.33 (0.55, 3.21) 
Ref 
Risk Score (Categorical) 
     High (≥40) 
     Moderate (30-39) 










1.59 (0.42, 5.99) 
1.18 (0.38, 3.63) 
Ref 
Gender 
     Male 









0.54 (0.29, 0.99) 
Race 
     White 
     Non-Hispanic Black 
     Hispanic 













.96 (0.51, 1.81) 
0.62 (0.22, 1.69) 
0.96 (0.26, 3.53) 
Age SD = 13.63 Mean = 42.89 1.0 (0.98, 1.02) 
Education 
     ≤High School 









0.91 (0.51, 1.61) 
Previous HIV Test 
     Ever 









0.62 (0.31, 1.23) 
Relationship Status 
     Married/Partnered 
     Divorced/Separated 
     Widowed 













2.20 (1.00, 4.85) 
1.15 (0.30, 4.39) 
1.47 (0.72, 3.01) 
Sexual Orientation 
     Heterosexual 
     Bisexual 
     Homosexual 













2.11 (0.54, 8.23) 
1.76 (0.61, 5.02) 
- 
# of Sexual Partners 
     0-1 
     2-5 
     ≥6 













2.76 (1.27, 5.98) 
2.56 (0.85, 7.82) 
1.46 (0.72, 2.96) 
Sex with Opp. Gender 
     Ever 









1.43 (0.38, 5.28) 
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Table 9 continued. 
Variable Name 2009 Opt-Out –Feel at risk for being infected with HIV 
     Agree (n=56)            Disagree (n=288)                    OR (95% CI) 
Sex with Same Gender 
     Ever 









0.75 (0.33, 1.73) 
Previous STD 
     Ever 






 226 (84.6%) 
 
Ref 
0.75 (0.39, 1.44) 
Injected Street Drugs 
     Ever 









0.53 (0.25, 1.12) 
 
For the full logistic model, I included all the main predictor and all covariates.  While 
the overall trends stayed consistent with the univariate analysis, nothing remained 
statistically significant in the full model.  After running for the full model, I fit a stepwise 
model to determine if the program would deem the primary predictor or any of the covariates 
statistically significant.  The only variable retained in the stepwise model was number of 
sexual partners.  Furthermore, only the 2-5 sexual partners category had a statistically 
significant estimate (OR=2.76, 95% CI: 1.27, 5.98) when compared to the 0-1 sexual partner 
category.   
 Purposeful modeling was utilized to fit the most parsimonious model.  Similar to the 
univariate analysis, the final model and variables included in the model were not strongly 
associated with the outcome of interest.  The final model included HIV risk, previous HIV 
test, sex with the same gender, number of sexual partners, and gender.  With the exception of 
sexual partners, all other variables included did not significantly contribute to the model 









Table 10: Aim 2 parsimonious model with HIV risk treated as a continuous variable 
modeling feeling at risk for HIV infection.   
Predictor Odds Ratio Estimate 95% CI 
HIV Risk 1.02 0.98, 1.07 
Previous HIV Test (Ref = Ever) 





# of Sexual Partners (Ref = 0-1) 
    2-5 
     6+ 









Sex with the same gender (Ref = Ever) 












Table 11: Aim 2 parsimonious model with HIV risk treated as a categorical variable 
modeling feeling at risk for HIV infection. 
Predictor Odds Ratio Estimate 95% CI 
HIV Risk (Ref = <30) 
     30-39 







Previous HIV Test (Ref = Ever) 





# of Sexual Partners (Ref = 0-1) 
    2-5 
     6+ 









Sex with the same gender (Ref = Ever) 












 Although nonsignificant, the effect size of sex with the same gender is interesting in 
the final model compared to the univariate analysis.  In the univariate analysis, never having 
sex with the same gender seemed to be protective for feeling at risk of HIV infection 
(OR=0.75).  In the model where risk is treated as a categorical variable, the estimate of sex 
with the same gender is attenuated but still has a protective trend (OR=0.95).  However, in 
the model where risk is treated as a continuous variable, the estimate of sex with the same 
gender is no longer protective (OR=1.22).   
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Preferred HIV Testing Somewhere Other than the ED.  The third barrier question 
assessed whether a patient would rather have been tested for HIV somewhere other than the 
emergency department.  About 17% of the survey respondents agreed that they would have 
rather been tested for HIV at a location other than the ED.  From the univariate analysis, 
none of the covariates were significantly associated with the outcome of interest (Table 12).  
When risk score was treated as a continuous variable, there appeared to be a positive trend 
between risk and testing location.  For every point increase in risk score, the odds that the 
patient would rather be tested for HIV at a location other than the ED increased by 2% (95% 
CI: 0.98, 1.05).  However, when treated as a dichotomous variable, the odds of preferring 
testing at a location other than the ED among high-risk patients was about 19% lower in 
comparison to low risk patients (95% CI: 0.30, 1.05).  When treated as a categorical variable, 
the odds of wanting a different testing location was about 50% lower for moderate patients in 
comparison to low risk patients (95% CI: 0.11, 2.20), whereas the odds were about 1.4 times 
higher for high risk compared to low risk patients (95% CI: 0.38, 5.40).  Due to the 
nonsignificant confidence intervals, it is not possible to definitely defend these differences, 
but does potentially point to an interesting trend.   
Table 12: Aim 2 descriptive statistics and univariate analysis of the primary predictor 
and covariates modeling the probability of rather being tested for HIV somewhere 
other than the emergency department.   
Variable Name 2009 Opt-Out – Rather had testing at other location 
    Agree (n=54)               Disagree (n=260)                OR (95% CI) 
Risk Score Mean = 21.30 SD = 8.34 1.02 (0.98, 1.05) 
Risk Score (Binary) 
     High (≥30) 








0.81 (0.30, 2.21) 
Ref 
Risk Score (Categorical) 
     High (≥40) 
     Moderate (30-39) 








231 (82.5%)  
 
1.41 (0.38, 5.4) 
0.50 (0.11, 2.20) 
Ref 
Gender 
     Male 









0.80 (0.44, 1.46) 
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Table 12 continued. 
Variable Name 2009 Opt-Out – Rather had testing at other location 
    Agree (n=54)               Disagree (n=260)                OR (95% CI) 
Race 
     White 
     Non-Hispanic Black 
     Hispanic 













0.91 (0.48, 1.75) 
0.58 (0.21, 1.61) 
0.66 (0.14, 3.10) 
Age Mean = 42.92 SD = 13.75 1.01 (0.99, 1.03) 
Education 
     ≤High School 









1.55 (0.85, 2.82) 
Previous HIV Test 
     Ever 









1.09 (0.59, 2.06) 
Relationship Status 
     Married/Partnered 
     Divorced/Separated 
     Widowed 
     Single/Never Married 
 
18 (17.3%) 










1.03 (0.45, 2.35) 
0.80 (0.21, 2.99) 
1.00 (0.51, 1.99) 
Sexual Orientation 
     Heterosexual 
     Bisexual 
     Homosexual 













0.46 (0.06, 3.69) 
0.77 (0.22, 2.71) 
<0.001 
# of Sexual Partners 
     0-1 
     2-5 
     ≥6 













0.84 (0.32, 2.19) 
1.64 (0.50, 5.41) 
1.40 (0.71, 2.74) 
Sex with Opp. Gender 
     Ever 









2.23 (0.66, 7.53) 
Sex with Same Gender 
    Ever 









1.47 (0.55, 3.96)  
Previous STD 
     Ever 









0.68 (0.30, 1.52) 
Injected Street Drugs 
     Ever 









0.68 (0.30, 1.52) 
 
After performing univariate analysis, a multivariable model that included the primary 
predictor and all potential covariates was fit.  After fitting the full model, none of the 
covariates significantly contributed to the model but maintained the same trends as the 
estimates from the univariate analysis.  Selective modeling was used to build the most 
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parsimonious and biologically plausible model.  The final model included HIV risk, race, 
education, and number of sexual partners (Table 13, 14).   
 The effect sizes in the parsimonious model remained similar to the estimates from the 
univariate analysis, but overall did not reach statistical significance.  As a continuous 
variable, the probability of rather being HIV tested at a location other than the ED increased 
by about 2% (95% CI: 0.99, 1.06) for every point increase HIV risk.  When treated as a 
categorical variable, the odds of wanting tested somewhere other than the ED among 
moderate patients was about 40% lower in comparison to low risk patients (OR=0.58, 95% 
CI: 0.13, 2.67).  The odds of preferring a different HIV location were modestly higher for 
high risk patients in comparison to low risk patients (OR=1.14, 95% CI: 0.28, 4.60).  Non-
Hispanic Black patients had a lower odds of wanting tested at a location other than the ED in 
comparison to white patients (OR=0.68, 95% CI: 0.24, 1.94).  Higher education (OR=1.51, 
95% CI: 0.80, 2.84) and a higher number of sexual partners (OR=1.59, 95% CI: 0.45, 5.57) 
was non-significantly associated with a larger odds of wanting to be tested for HIV at a 
location other than the ED.   
Table 13: Aim 2 parsimonious model with HIV risk treated as a continuous variable, 
modeling preferring testing at a location other than the emergency department. 
Predictor Odds Ratio Estimate 95% CI 
HIV Risk  1.02 0.99, 1.06 
Race (Ref = White) 
     Hispanic 
     Non-Hispanic Black 









# of Sexual Partners (Ref = 0-1) 
    2-5 
     6+ 









Education Level (Ref = ≤High School) 









Table 14: Aim 2 parsimonious model with HIV risk treated as a categorical variable, 
modeling preferring testing at a location other than the emergency department. 
Predictor Odds Ratio Estimate 95% CI 
HIV Risk (Ref = <30) 
     30-39 







Race (Ref = White) 
     Hispanic 
     Non-Hispanic Black 









# of Sexual Partners (Ref = 0-1) 
    2-5 
     6+ 









Education Level (Ref = ≤High School) 






 Fear of Different Treatment.  The final barrier question aimed to measure patients’ 
fear of being treated differently if their HIV test result was positive.  155 out of the 327 
(47%) patients agreed to the statement for feeling at risk of different treatment if their HIV 
test result was positive.  Univariate analysis of the primary predictor (HIV Risk) and all 
potential covariates was performed initially to establish if any of the variables were 
independently associated with the outcome (Table 15).  None of the covariate were 
significantly associated with the outcome and overall, there were very few notable trends.   
 From the univariate results of HIV risk, there was no difference in the odds of feeling 
afraid of different treatment between risk groups.  The odds of feeling afraid of different 
treatment was slightly higher for patients with higher education (OR=1.29, 95% CI: 0.85, 
1.94).  Additionally, there seemed to be a general dose response trend with the number of 
sexual partners.  As the reported number of sexual partners increased, the odds of fearing 
different treatment if tested positive for HIV also increased.  Overall, the results from the 
univariate anlaysis were not highly conclusive and showed only weak potential trends 
between patients with different risk characteristics. 
  45 
Table 15: Aim 2 descriptive statistics and univariate analysis of the primary predictor 
and covariates modeling fear of different treatment by others if HIV test was positive. 
Variable Name 2009 Opt-Out – Afraid of Different Treatment 
 Agree (n=155)       Disagree (n=172)               OR (95% CI) 
Risk Score Mean = 21.18 SD = 8.24 1.01 (0.99, 1.04) 
Risk Score (Binary) 
     High (≥30) 








0.92 (0.45, 1.89) 
Ref 
Risk Score (Categorical) 
     High (≥40) 
     Moderate (30-39) 







11 (55.0%)  
154 (52.4%) 
 
0.94 (0.31, 2.87) 
0.90 (0.36, 2.24) 
Ref 
Gender 
     Male 









1.09 (0.70, 1.68) 
Race 
     White 
     Non-Hispanic Black 
     Hispanic 













0.92 (0.46, 1.82) 
0.66 (0.40, 1.07) 
1.20 (0.45, 3.21) 
Age Mean = 42.43 SD = 13.57 0.98 (0.97, 1.00) 
Education 
     ≤High School 









1.29 (0.85, 1.94) 
Previous HIV Test 
     Ever 









0.92 (0.57, 1.47) 
Relationship Status 
     Married/Partnered 
     Divorced/Separated 
     Widowed 













1.66 (0.89, 3.06) 
0.82 (0.32, 2.14) 
1.27 (0.77, 2.12) 
Sexual Orientation 
     Heterosexual 
     Bisexual 
     Homosexual 













1.11 (0.32, 3.93) 
1.11 (0.45, 2.76) 
<0.001 
# of Sexual Partners 
     0-1 
     2-5 
     ≥6 













1.76 (0.91, 3.39) 
2.12 (0.80, 5.64) 
0.95 (0.56, 1.60) 
Sex with Opp. Gender 
     Ever 









0.60 (0.20, 1.84) 
Sex with Same Gender 
     Ever 









0.95 (0.48, 1.87) 
Previous STD 
     Ever 









0.79 (0.46, 1.33) 
Injected Street Drugs 
     Ever 









0.54 (0.27, 1.04) 
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Following the univariate analysis, I fit a full multivariable regression model to 
include the primary predictor and all potential covariates of interest.  Similar to the results of 
the univariate analysis, none of the variables significantly contributed to the full model.  
Selective modeling was used to build the most parsimonious final model to include the 
primary predictor and covariates that had potential biological plausibility and statistically 
contributed to the model.  The final model included HIV risk, education level, and number of 
sexual partners (Table 16, 17).   
 The odds of being afraid of different treatment if the HIV test results were positive 
did not differ significantly by HIV risk.  When treated as a categorical variable, the odds of 
fearing different treatment was only slightly lower for both moderate and high risk patients in 
comparison to low risk patients (OR=0.83, 95% CI: 0.33, 2.12) (OR=0.87, 95% CI: 0.28, 
2.76).  Consistent with the univariate analysis, there was a potential dose response with the 
number of sexual partners and being afraid of different treatment.  Although not statistically 
significant, as the number of sexual partners increased, the odds of fearing different treatment 
also increased.  Finally, there was a slight difference by education level.  The odds of fearing 
different treatment among patients who had some college or more was about 1.2 times higher 
than patients who had a high school education or less (95% CI: 0.78, 1.90).  Based on these 
models, it does not appear that HIV risk is associated with fear of different treatment.  
Table 16: Aim 2 parsimonious model with HIV risk treated as a continuous variable, 
modeling fear of different treatment if the HIV test results were positive. 
Predictor Odds Ratio Estimate 95% CI 
HIV Risk  1.01 0.99, 1.04 
# of Sexual Partners (Ref = 0-1) 
    2-5 
     6+ 









Education Level (Ref = ≤High School) 






Table 17: Aim 2 parsimonious model with HIV risk treated as a categorical variable, 
modeling fear of different treatment if the HIV test results were positive. 
Predictor Odds Ratio Estimate 95% CI 
HIV Risk (Ref = <30) 
     30-39 







# of Sexual Partners (Ref = 0-1) 
    2-5 
     6+ 









Education Level (Ref = ≤High School) 






Non-Linear HIV Test Acceptance Probability Aim 3 Results  
B-splines are widely used in statistically modeling, allowing a flexible plot without 
imparting a restrictive structure on the data
33
.  B-spline plots of both unadjusted and adjusted 
models were fit in R.  Unadjusted plots only included HIV risk score as the predictor, 
measuring the probability of HIV test acceptance.  The adjusted plots fit the probability of 
HIV test acceptance based on HIV risk, age, and the reference groups of time of ED visit, 
race, previous HIV test, and perception of routine HIV screening in the emergency 
department.  The AICs were used to determine plot best fit the data (Table 18). 
Table 18: AICs of B-spline and polynomial models used to measure the non-linear 
relationship of HIV risk and probability of HIV test acceptance. 
Model AIC 
Unadjusted linear polynomial 727.39 
Unadjusted quadratic polyomial  729.03 
Adjusted linear polynomial 704.86 
Adjusted quadratic polynomial  706.86 
Adjusted B-spline 4 degrees of freedom 705.83 
Adjusted B-spline 4 degrees of freedom – age and race removed 706.68 
 
 Based on the AIC value of the B-spline and polynomial plots, the adjusted linear 
model has the overall best fit.  The adjusted plot with four degrees of freedom also has a 
comparably low AIC in comparison to the linear plot.  The B-spline plot with 4 degrees of 
freedom also had a comparably low AIC value, within 1 point from the adjusted linear model 
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(Figure 3).  Furthermore, all adjusted models have a comparable AIC to the adjusted linear 
model, with a difference less than 2.  This may be partially due to the sparse amount of data 
points in the tails of the Denver HIV Risk Score outcome and the strategy of placing knots at 
the quantiles.  Future B-spline models could fit different knot locations to determine the ideal 




























Figure 3: B-spline plot with 4 degrees of freedom, adjusted for HIV risk, age, race, 
previous HIV test, visit time to the emergency department, and perception of routine 









Interpretation of Results 
 
 The aim 1 results were generally consistent with the findings from previous studies.  
Although HIV risk was not statistically significant in the univariate or multivariable analysis, 
the general positive trend in test acceptance provided some evidence that disproved my 
original hypothesis.  I had expected that there would be a discordant relationship between 
HIV risk and test acceptance, hypothesizing that a higher HIV risk would be associated with 
a lower odds of test acceptance.  However, aim 1 results seemed to be exactly the opposite.  
As patient HIV risk increased, the odds of accepting a rapid HIV test also increased.  In the 
original directed acyclic graph, one of the concerns was the unmeasured perception of HIV 
risk.  While the HIV risk measurement provides an objective empirically based estimate of a 
patient’s risk, it does not necessarily mean that patient’s accurately perceive their personal 
risk.  Previous studies have determined that people generally understand their individual risk 
for HIV, but overall tend to underestimate their risk
19,20
.  These concordant results provided 
evidence in support of Health Belief Model.  The Health Belief Model states that individuals 
who feel at risk or threatened by a disease or illness will be more empowered to take steps for 
prevention
18,19
.  From our data, we can hypothesize that high risk patients recognize their 
personal risk and are therefore more influenced to accept a test in comparison to low risk 
patients. 
 The significant differences in test acceptance by race were also consistent with the 
previous findings in the literature.  In comparison to white patients, patients who identified as 
Bon-Hispanic Black and those who identified as Asian, American Indian/Alaskan Native, or 
other had increased odds of accepting an HIV test.  There is a strong body of evidence that 
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demonstrates that African-Americans tend to have higher frequency of HIV test acceptance 
in comparison to other races and ethnicities in the United States
20,30
.  While the odds of test 
acceptance was higher for patients who identified as “Other” in the survey, I suspect the true 
effect is distorted because multiple races had to be combined due to small sample size.  
Currently, the American Indian/Alaskan Native population is experiencing one of the highest 
increases in HIV infection rates in the United States, but often goes unnoticed because of 
their small size
31
.  In early analysis when the American Indian/Alaskan Native group was 
analyzed as an independent group, the odds of test acceptance were the highest out of all 
racial groups.  However, due to the small cell sizes the American Indian/Alaskan Native 
category was combined into “Other” which attenuated the true effect.  It was slightly 
surprising to see no difference of test acceptance between Hispanic patients and white 
patients.  In a study conducted by Lopez-Quintero et al. they pointed to differences in testing 
behaviors within Hispanic and Latin American ethnicities
32
.   They found that Mexican and 
Mexican-Americans were less likely to have ever been tested than Puerto Ricans, and that 
Cubans were less likely to report ever having the intention to be tested
32
.  Perhaps the lack of 
granularity in the survey and grouping all Hispanics together, regardless of ethnicity, 
attenuated the potential differences.   
 It was also surprising that there was no difference between the rates of acceptance by 
gender.  Previous literature has provided evidence that females may be likely to accept 
testing than men, perhaps due to more regular contact with healthcare providers, prenatal 
recommended screening, or gynecologic screening
17,32
.  Another study conducted by Bond et 
al. suggested that women’s higher likelihood of being stemmed from knowing someone who 
had HIV/ADIS, perceiving themselves as higher risk, or wanting to know health related test 
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results more than men
32
.  While a significant association wasn’t present in the aim 1 
regression models, gender differences were present in aim 2 when looking at the barriers to 
accepting a rapid HIV test.  In contrast to Bond’s qualitative findings, the odds of feeling at 
risk for HIV infection among women was about half (OR=0.54, 95% CI: 0.29, 0.99) as likely 
in comparison to men.  Although these results did follow the same trend as Bond’s findings, 
it did point to potential differences in testing attitudes, risk perception, and test acceptance by 
gender, that could be further explored.   
 Although not significant in the multivariable model, time of emergency department 
visit was an interesting finding in the univariate analysis.  Patients who presented to the ED 
during the evening hours (18:00-22:59) were about 1.5 times more likely to accept an HIV 
test than patients who presented during the daytime hours (08:00-17:59).  Likewise, patients 
who presented during the night hours (23:00-7:59) were about 30% less likely to accept a test 
in comparison to patients who presented during the daytime hours.  This potentially provides 
some insight for deciding when to approach patients to offer a rapid HIV test  If patients are 
more likely to accept during the evening hours, then emergency department staff may be able 
to target more of their efforts to a time that would receive a better response.   
 It was not overly surprising that patients who received an HIV test within the past 12 
months were more likely to decline a test offered during their ED visit.  It is possible that 
patients who had received an HIV test within the past year did not feel that they were at risk 
and would need to get tested again.  This introduces an interesting secondary question for the 
adequate frequency of testing.  For high risk patients, is HIV testing once a year sufficient or 
is this a false sense of security?  Also, how do healthcare providers encourage and empower 
patients to get tested when they do not feel they need one?  
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 The results from the secondary aim models also provided a lot of insight into the 
patient attitudes and perceptions towards HIV testing and their personal risk of infection.  In 
both the univariate and multivariable regression models, HIV risk was significantly 
associated with being afraid of the HIV test results.  In the adjusted model on the 
multiplicative scale, for every increase in point on the HIV risk score the odds of being afraid 
of the test results increased by 5%.  This concordant increase of HIV risk and being afraid of 
the test results is very telling of people’s perceptions of their risk.  Seeing the positive 
relationship between HIV risk and fear of the HIV test results provides evidence that people 
are aware of their HIV risk.   It is possible that perceiving oneself at risk and being afraid of 
test results would dictate their decision to accept or decline an HIV test in the emergency 
department.   
 Another facet of the aim 2 analyses that helped to clarify people’s perceptions of their 
risk was the differences in fear of the HIV test result and exposure to different risk behaviors.  
In both the univariate and multivariable models, fear of the test result differed by the 
patient’s reported number of sexual partners.  As the number of sexual partners increased, the 
odds of the participant being afraid of their test result also increased.  This provides 
additional evidence that people understand the risk behaviors they engage in and 
consequentially either feel afraid of their HIV test results or do not feel afraid.  Although 
they did not significantly contribute to the final model, sex with the same gender, injection of 
street drugs, sexual orientation, and relationship status followed a similar trend as number of 
sexual partners.  In the univariate analysis those who reported never to having sex with the 
same gender and never injecting street drugs were much less likely to feel afraid of their HIV 
test results.  Similar to the number of sexual partners, these findings infer that patients are 
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aware that they are engaging in HIV related risk behavior and this awareness is reflected in 
the fear of their HIV test results.  
 The barrier outcome models for feeling at risk of HIV infection was more difficult to 
fit, fearing different treatment, and preferring HIV testing at a location other than the 
emergency department were more difficult to fit.  While most of the covariates followed the 
same trend as the fear of the HIV test result model, only gender and number of partners were 
significantly associated with feeling at risk of HIV.  Fear of different treatment and 
preferring HIV testing at a location other than the ED were the most difficult barrier 
outcomes to model.   When evaluated univariately, none of the variables were independently 
associated with the outcome nor exhibited very notable trends.  It was more difficult to 
decide which variables to include in the final because all the potential associations had very 
weak estimates.  I did not feel that the models were statistically as robust or that they were 
accurately capturing the true association between HIV risk and the outcome of interest. In 
comparison to the last two models, my confidence in the models fitting fear of the HIV test 
results and feeling at risk for HIV infection models are much larger.   
 The results for the B-spline plots provided interesting insight into the true relationship 
between HIV risk and the probability of test acceptance.  From my original hypothesis, I 
thought there would be a quadratic relationship between HIV risk and test acceptance.  This 
assumed that very low risk patients and very high risk patients would have a lower 
probability of accepting a test than the patients with low to moderate risk.  Although the B-
spline model did not reach the 0.05 alpha level, the plot that allowed 4 degrees of freedom 
was the most biologically reasonable and had the best AIC.  In agreement with the original 
hypothesis, patients with very low HIV risk concurrently had a low probability of accepting 
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the HIV test.  In prose terms, I would refer to this as the “nun effect”.  The population at very 
low risk could be aware that they have little to no risk of contracting HIV and therefore 
would be more likely to decline the test.  It appeared that the probability of accepting a test 
reached a maximum around a score of 39 and then began to decrease as the HIV risk scores 
approached their maximum value.  This was somewhat consistent with my original 
hypothesis, although not the extent that I had believed the probability of test acceptance 
would decrease as the risk scores reached their highest value.  With the exception of the dip 
in probability for scores around 21-26, the gradual rise in risk score concordant with the 
increased probability of test acceptance was consistent with the original hypothesis.  One 
potential explanation for this dip was the disproportionate number of data points in the 20’s 
in comparison to the number of data points below 20.  It is possible that the B-spline was 
attempting to correct for the lack of data points and imputing an extra dip in the data because 
of the high number of data points in the 20’s.   
Study Strengths 
One of the main strengths of this study was the novelty of the research question.  This 
is one of the first studies to utilize patient satisfaction surveys nested within a larger quasi-
experimental study to look at acceptance of HIV testing in the emergency department.  
Furthermore, the ability to apply the Denver Health Risk Score to the survey cohort 
retroactively allowed us to use a novel primary predictor to study the association between 
HIV risk and test acceptance.  While we did not directly have a measure of HIV risk 
perception, we were able to infer risk perception information from the data available.  There 
were multiple facets of routine HIV screening research gaps that were explored in this study.  
Being able to identify significant characteristics, attitudes, and demographics associated with 
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HIV test acceptance and identify risk behaviors associated with barriers to accepting a rapid 
HIV test, are important pieces of understanding when implementing a routine screening 
program. 
 Many of the prior studies provided qualitative evidence of factors that influenced test 
acceptance and barriers to testing, using methods such as focus groups, interviews, and 
literature reviews of.  However, there were a limited number of quantitatively driven studies 
that evaluated attitudes, characteristics, HIV risk, and demographic associated with HIV test 
acceptance.  
 Another strength of the study was the diverse population captured in the survey data.  
The Denver Health emergency department was an ideal location for conducting this research 
because they were able to access a representative sample of demographics that might not 
have been achieved if conducted in a different Colorado health care setting.  While the 
findings may not be generalizable to all healthcare environments, it could provide a 
foundation of understanding, particularly for urban emergency department settings. 
Study Limitations 
There were several study limitations that are important to address.  As a cross-
sectional survey, many of the results and conclusions are limited by the design of the study.  
With cross-sectional data, it is not possible to establish a temporal sequence and therefore we 
are unable to draw a causal association between exposure and outcome.  In addition, there are 
several challenges and potential biases inherent to working with survey data.  One of the 
largest challenges could have been the way the survey was administered.  While the survey 
was administered person-to-person, it is possible that social norm bias occurred if 
participants felt they would be judged for their risk behaviors.  If they were afraid of a 
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negative stigma or disclosing the information to the research assistant, it is possible that their 
responses could be inaccurate.   
 Another challenge with the working with the survey data was encountering missing 
data or “no response” answers.  In cases such as the barrier outcome data where many of the 
responses were “no answer”, “don’t know” or missing, it was difficult to try and rationalize 
the reasons the data was missing.  It was also difficult trying to collapse categories or 
combine “don’t know” responses with other categories because I didn’t feel confident in 
reclassifying them.  One of the notable limitations was loss of observations and information 
due to the non-response, missing, and “don’t know” responses that had to be excluded from 
the analysis.  In a study with an already limited number of observations, these responses 
could have potentially had a sizeable impact on the study results.   
 As mentioned above, the sample size was overall adequate for aim 1 and aim 3, but 
could have been larger for aim 2.  Since aim 2 only included participants who declined the 
HIV test, it reduced the size of the dataset a little over 40%.  Further coupled by the deletion 
of missing, no response, and “don’t know” response, the results were hindered by the strain 
in sample size.  Many of the predictors exhibited a notable trend but could not reach 
statistical significance or had massive confidence intervals.  With a larger sample size, the 
precision of the results could be improved across the board.   
 Another notable limitation was the lack of a risk perception measurement.  Patient 
perception of their individual risk would have been an important confounder to control for.  
However, there was no specific measure of patient perception included in the survey.  Also, 
there was potential misclassification of the emergency department visit time variable.  
Technically, the time coded into the dataset would be representative of the survey 
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administration and not initial presentation to the ED.  Since patients had to have been in the 
ED for at least two hours to be eligible for the survey, it is possible that they presented in a 
different time category than the time recorded in the dataset.  Finally, although the chances 
are small, it is possible that repeat patients were surveyed more than once.  Since the data 
was de-identified upon collection, it was not possible to see if any patient was surveyed more 
than once during the study period.  Randomly selecting 8-hour periods to conduct survey 
collection most likely helped to mitigate this issue.  However, it is still a potential that could 
have biased the results.   
Future Directions 
 Further expansion of this research would be extremely beneficial for improving the 
understanding and body of evidence for routine HIV screening in healthcare settings.  I 
would first set a precedent to update the current patient satisfaction surveys so they include 
questions that specifically address patient perception of their risk.  I would also reformat the 
survey so that the current barrier to HIV testing questions were answered by all patients, not 
only those who declined the HIV test.   
In the current surveys, there are a series of questions addressing if patients felt that 
the HIV testing process was voluntary and confidential.  Also included in the survey were 
questions evaluating whether the patient felt they were provided enough information and 
were aware of their decision to get an HIV test.  These questions focusing on confidentiality 
and voluntariness could also help inform a better understanding patient’s decision to accept 
or decline an HIV test.  In an already high stress environment such as the emergency 
department, patients’ judgment and decision-making may be altered.  Another set of studies 
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could be conducted to evaluate differences in test acceptance by perceptions of 
confidentiality, voluntariness, and HIV testing understanding.   
 Implementation of routine screening is a two-way relationship.  While patients make 
their ultimate decision for accepting or declining a test, ED staff must first be willing and 
able to offer routine screening.  An additional future study could identify challenges, barriers, 
and concerns of routine HIV screening from the provider perspective.  The implementation 
of routine HIV screening would only be successful if providers perceive screening as a 
valuable intervention and feel that they have the resources offer a screening program. 
 Finally, it would be beneficial to conduct this type of study in other emergency 
departments or other healthcare settings beyond the ED.  The findings in this study are not 
necessarily generalizable to other populations and it would be interesting to compare the 
patient perceptions and attitudes towards testing in a variety of clinical environments.  I 
would be especially interested to see if the findings differed in populations with a higher 
prevalence of African-American patients, Asian patients, or American Indian/Alaskan Native 










 While great strides have been made in the prevention of HIV infection, it remains a 
high priority public health concern.  Although the rates in the United States are decreased 
significantly in the past two decades, the disease continues to disproportionately affect 
certain populations.  To address the persistent challenge of decreasing the number of infected 
individuals who remain undiagnosed, the CDC increased their recommendations to routine 
HIV screening in all healthcare settings
13
.  While this new initiative opens the door to 
widespread rapid HIV testing, it also presents new challenges and new gaps in 
understanding.   
 HIV risk, perception of HIV risk, screening methods, and patient test acceptance 
forms a delicate and multi-faceted relationship that must be considered before implementing 
a routine HIV screening program.  It is critical to understand what factors determine whether 
a patient will decline or accept an HIV test.  Specifically, patient HIV risk and perception of 
their individual HIV risk are important factors that could influence test acceptance.  While 
these two factors are not always in congruence, they help to set the infrastructure in 
measuring the likelihood that a patient will get tested.   
 In this study, we aimed to identify characteristics, risk behaviors, and demographics 
associated with a patient’s probability of accepting a rapid HIV test during their visit to the 
Denver Health emergency department.  Using the Denver HIV Risk Score, we hypothesized 
that a patient’s HIV risk would be discordantly associated with their probability of accepting 
a test.  In contrast, we hypothesized that there would be a concordant relationship between 
HIV risk and positively identifying with the barriers to HIV testing outlined in the survey.   
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 The statistical findings were overall consistent with the previous literature and  
representative of the study population.  Although it did not reach statistical significance, the 
multivariable model exhibited a concordant trend, where the odds of test acceptance 
increased as patient HIV risk increased.  This was seen both on the additive and 
multiplicative scale when HIV risk was treated as a continuous, dichotomous, and categorical 
variable.  In the secondary aim, increased risk of HIV was associated with higher odds of 
fearing the HIV test result in both the univariate and multivariable regression models.  
Higher HIV risk was independently associated with increased odds of feeling at risk for HIV 
infection, although it did not remain statistically significant in the multivariable model. 
 Additionally, African-American patients and patients who identified as American 
Indian/Alaskan Native, Asian, and “other” had higher odds of accepting an HIV test in 
comparison to white patients.  Patients who had reported having an HIV test within the last 
12 months and patients who did not believe routine HIV screening occur in the ED were less 
likely to accept an HIV test.  After controlling for previous HIV tests, education level, and 
sex with the same gender, increasing HIV risk and number of sexual partners were 
significantly associated with fearing the results of the HIV test.   
 In accordance to the original hypothesis, we found a non-linear relationship between 
HIV risk and probability of test acceptance.  Patients in the lowest end of the low risk 
category had the smallest probability of accepting an HIV test.  The probability gradually 
increased with increasing HIV risk score until scores reached the high risk group, where the 
probability began to decrease again.  Although the B-spline model was overall not 
statistically significant, it provided a general representation of the data with very little 
restrictions on the shape.    
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From a public health standpoint, these results provide an important understanding of 
patient behaviors, attitudes towards testing, and patterns of test acceptance.  From this study, 
we have confirmed that patient test acceptance can vary by a number of different factors.  In 
moving forward with implementation of routine screening, it will be important to note these 
differences and potentially adapt the way patients are approached.  Also, this study provides 
insight into the barriers to testing that might influence patients to decline an HIV test.  By 
quantifying these barriers and understanding the patient factors that determine these barriers, 
providers can work to breakdown these perceived barriers.  Our findings support the concept 
that patients are aware of their risk of HIV infection.  This is shown in both the test 
acceptance and barrier related outcomes.  Patients who are at higher risk are more likely to 
get accepted, but also more likely to fear their test results.  Also, patients who engaged in 
higher risk behavior were more likely to fear their test results and feel at risk for being 
infected with HIV.    
Knowing that patients are overall cognizant of their risk could potentially help guide 
the approach that the Denver Health providers utilize when offering a patient an HIV test.  If 
higher risk patients are more aware of their risk and more likely to accept a test, then perhaps 
nontargeted opt-out methods are not the most efficient method.  Targeted opt-in screening 
might be a better approach to employ because it empowers the patients to know their risk and 
make a decision accordingly.  Offering a routine test to every patient who presents to the ED 
might be an inefficient use of staff and resources, especially if the low risk patients are more 
likely to decline a test regardless. 
This study lays an intriguing infrastructure for further studies that could be conducted 
in the Denver Health ED or any other healthcare setting. The attitudes, demographics, 
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behaviors, and characteristics witnessed in the Denver Health ED patient population may not 
be the same as other clinical settings.  However, the basic design of the survey, use of the 
Denver Health Risk Score to evaluate patient HIV risk, and application would be beneficial 
for any healthcare setting planning to implement routine screening.  In the future, further 
studies using this data or an expanded version of this data would be useful for decision 
making and gaining a better understanding of the patient population.   
 Routine HIV screening in the emergency department, let alone any healthcare setting, 
requires a multi-faceted approach that takes into account the complex relationship between 
system, environment, patient, and provider.  The goal of this study was to quantitatively 
examine the patient component and identify trends, perceptions, behavior, and demographics 
that could influence their acceptance of an HIV test.  This research could provide a 
foundation for studying patient acceptance patterns in a variety of clinical environments, 
particularly to fulfill the need in communities that could benefit from routine HIV screening.   
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